Press release
Pharyngitis Market Size Reaching US$ 2.08 Billion by 2034 | Fact.MR
Pharyngitis Market
Get Free Sample Research Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=361
In recent years, effective medications, including NSAIDs (non-steroidal anti-inflammatory drugs), antibiotics, antivirals, etc. have been adopted for the management of disease symptoms or treatment of ailments, which is further contributing to pharyngitis market growth. In addition, the inflating application of throat sprays or lozenges, containing numbing agents, menthol and lozenges, to relieve pain and discomfort by soothing the irritated tissues, is further contributing to the expansion of the pharyngitis market size.
Key Market Trends and Drivers:
Adoption of Effective Medications:
Medications such as NSAIDs (non-steroidal anti-inflammatory drugs), antibiotics, and antivirals have been increasingly adopted to manage pharyngitis symptoms. The availability of throat sprays and lozenges containing numbing agents and menthol is also contributing to market growth.
Emergence of Photobiomodulation Therapy:
Photobiomodulation therapy, which uses low-level lasers or light-emitting diodes to stimulate cellular function and promote healing, is gaining popularity and driving new opportunities for market players.
Rising Demand for Over-the-Counter (OTC) Medicines:
The convenience of OTC medications, which do not require a doctor's prescription, is boosting their popularity. Products like throat sprays, pain relievers, and lozenges are readily available in retail and online pharmacies, making them a preferred choice for many patients.
Advancements in Novel Therapeutics:
The demand for novel therapeutics that offer better patient outcomes with minimal side effects is rising. Manufacturers are focusing on developing advanced treatments that are more effective and safer for patients.
Regional Insights:
North America:
North America is expected to hold a significant market share, accounting for 35.9% of the global market by 2034. The United States, with its advanced healthcare infrastructure and supportive reimbursement policies, will be a major contributor, with an anticipated market value of $673.1 million by 2034, growing at a CAGR of 4%.
China:
China is another key market, projected to reach $184.6 million by 2034, with a CAGR of 5.4%. The country's increased investment in healthcare R&D and infrastructure is driving demand for advanced pharyngitis treatment solutions.
Market Segmentation:
By Drug Class:
Beta Lactams: Expected to be the most preferred drug class, with projected sales of $776.3 million by 2034, growing at a CAGR of 3.7%.
Macrolides
Cephalosporins
Fluoroquinolones
Tetracycline
By Mode of Delivery:
Oral: The most common mode of delivery, expected to account for 42.2% of the market by 2034, with sales reaching $879.7 million.
Intravenous
Intramuscular
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies & Drug Stores: Anticipated to dominate with a 58.5% market share by 2034.
Online Pharmacies
Market Restraints:
Side Effects of Antibiotics:
The side effects associated with antibiotics, such as rashes, diarrhea, and dizziness, are limiting their demand. Patients are increasingly turning to natural remedies to avoid these side effects.
Availability of Alternative Treatments:
The availability of alternative treatments, including herbal remedies like ginger and honey, is also affecting the demand for conventional pharyngitis treatments.
Competitive Landscape:
Major players in the pharyngitis market include Pfizer Inc., Novartis AG, GlaxoSmithKline PLC, Zambon Group SpA, and BioStar Pharmaceuticals Inc. These companies are focusing on strategies such as mergers, acquisitions, and new product development to maintain a competitive edge.
Opportunities for New Entrants:
Startups can leverage the growing demand for customized treatment solutions that cater to individual clinical needs. Developing medications with minimal side effects and ensuring rapid healing can help new entrants establish a strong market presence.
Browse Full Report @ https://www.factmr.com/report/361/pharyngitis-market
Future Outlook:
The pharyngitis market is poised for steady growth over the next decade, driven by advancements in treatment options and a rising preference for OTC medications. With increasing investments in healthcare infrastructure and R&D, regions like North America and East Asia are expected to be key contributors to market expansion.
Related Publish by Fact.MR Industry:
Biorefinery Market:
https://www.factmr.com/report/biorefinery-market
Animal Drug Compounding Market:
https://www.factmr.com/report/animal-drug-compounding-market
Recycled Polyethylene Terephthalate (R-PET) Market:
https://www.factmr.com/report/r-pet-market
Polymer Blends & Alloys Market:
https://www.factmr.com/report/polymer-blends-and-alloys-market
𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharyngitis Market Size Reaching US$ 2.08 Billion by 2034 | Fact.MR here
News-ID: 3528051 • Views: …
More Releases from Fact.MR
Snacks Market is Growing at USD 569.2 billion in 2025 | Fact.MR Report
The global snacks market is projected to grow from USD 545.2 billion in 2026 to approximately USD 835.4 billion by 2036. This growth reflects a steady compound annual growth rate (CAGR) of 4.3% over the ten-year forecast period. The market is being fundamentally reshaped by the "snackification" of meals, where busy consumers are increasingly replacing traditional breakfast, lunch, and dinner with portable, nutrient-dense snacking options.
Get Access of Report Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=50
Quick…
Liquid Nutritional Supplement Market Growing from USD 42.0 billion in 2025 to US …
The global liquid Nutritional supplements market is projected to grow from USD 33.25 billion in 2026 to approximately USD 45.10 billion by 2036. This growth represents a compound annual growth rate (CAGR) of 6.1% to 10.2% depending on the specific product segment (e.g., high-growth Ready-to-Drink formulations vs. traditional tonics).
The market is being primarily driven by a "pill fatigue" trend among consumers and an aging global population that increasingly prefers…
FMCG Logistics Market is Expected to Hit USD 190.5 billion by 2036 | Fact.MR Ins …
The global FMCG logistics market is projected to grow from USD 126.9 billion in 2026 to approximately USD 189.5 billion by 2036. This growth reflects a steady compound annual growth rate (CAGR) of 4.1% over the ten-year forecast period.
The market is entering a decade of transformation, shifting from a focus on cost-driven efficiency to automation-led resilience as retailers and brands navigate the complexities of quick-commerce and global supply chain…
Bio-Based Ethyl Acrylate Market Forecasted CAGR of 12.6% by 2036 | Fact.MR Repor …
The global Bio-Based Ethyl Acrylate Market is projected to expand significantly over the next decade as demand for sustainable, performance-oriented monomers rises across coatings, adhesives, textiles, and specialty chemical applications. Industry analysts estimate that the market, valued at approximately USD 450 million in 2025, is expected to reach around USD 940 million by 2035, representing a compound annual growth rate (CAGR) of about 7.9% over the forecast period.
Get Access of…
More Releases for Pharyngitis
Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
What Is the Expected CAGR for the Pharyngitis Treatment Market Through 2025?
The market for pharyngitis treatment has seen consistent growth over the past few years. The predicted expansion is from $2.27 billion in 2024 to $2.37 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%.…
Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment …
The Pharyngitis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Pharyngitis Treatment Market Size and Projected Growth Rate?
In recent times, there has been a consistent increase in the size of the pharyngitis treatment market. It is projected to expand from $2.27…
Revolutionizing Relief: Contemporary Approaches to Pharyngitis Treatment
Pharyngitis is a disorder that is typically characterized by the inflammation of the pharynx. It is most commonly known as sore throat. It causes pain, discomfort and scratchiness in the throat that further leads to difficulty in swallowing. The most common cause of its occurrence is due to viral infections such as common cold, influenza and others. The early treatment is essential to relive the pain. The typical symptoms includes…
Pharyngitis Market Future Forecast Indicates Impressive Growth Rate
Pharyngitis also known as pharynx is inflammation of the back of the throat resulting in a sore throat. It may be bacterial or viral, the most common bacteria that infect human throat is Group A Streptococcus. Various market players are working on developing rapid diagnostic testing solutions for the fast detection of infection to provide treatment at an early stage. According to the medical professionals, around 50% of a sore…
Pharyngitis Therapeutics Market - Regional Insights
Pharyngitis treatment is majorly based on the symptoms, depending the cause of pharyngitis for example, bacterial, fungal, and herpes simplex infections. The common symptoms of pharyngitis include sneezing, runny nose, headache, cough, fatigue, body aches, chills, and fever. Additionally, strep throat condition also occurs, which may lead to difficulty in swallowing, loss of appetite, nausea, fever, loss of taste, and swollen lymph nodes. Pain medication such as NSAIDs and…
Researchers Discover Potential of Pharyngitis Therapeutics Market
Pharyngitis Therapeutics Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Pharyngitis Therapeutics Market research report is a professional and in-depth study on the current state of Pharyngitis Therapeutics Industry.
The Pharyngitis Therapeutics Market research report covers the present scenario and the growth prospects of…
